SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-048470
Filing Date
2023-09-18
Accepted
2023-09-18 08:10:44
Documents
14
Period of Report
2023-09-15
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcon-20230915.htm   iXBRL 8-K 58819
2 EX-99.1 tcon-ex99_1.htm EX-99.1 27548
3 GRAPHIC img65184791_0.jpg GRAPHIC 23452
  Complete submission text file 0000950170-23-048470.txt   241253

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcon-20230915_pre.xml EX-101.PRE 9461
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcon-20230915.xsd EX-101.SCH 2481
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcon-20230915_lab.xml EX-101.LAB 12806
8 EXTRACTED XBRL INSTANCE DOCUMENT tcon-20230915_htm.xml XML 4550
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 342037594 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 231260148
SIC: 2836 Biological Products, (No Diagnostic Substances)